Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.

@article{Schoels2010EconomicAO,
  title={Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.},
  author={M Schoels and John Wong and David Lloyd Scott and Angela Zink and Pamela Richards and Robert L Landew{\'e} and Josef S Smolen and Daniel Aletaha},
  journal={Annals of the rheumatic diseases},
  year={2010},
  volume={69 6},
  pages={995-1003}
}
OBJECTIVE To review the cost effectiveness of rheumatoid arthritis (RA) treatments and inform the clinical recommendations by the European League Against Rheumatism. METHODS A systematic literature search and review of the health economic evidence on RA treatment options was performed. RESULTS Despite diverse methodological approaches, health economic analyses are concordant: at onset of disease, traditional disease-modifying antirheumatic drugs (DMARDs) are cost effective-that is… CONTINUE READING
70 Citations
72 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 70 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 72 references

Cost - effectiveness of using etanercept as fi rst line treatment in severe and highly active rheumatoid arthritis patients [ abstract ]

  • B Fautrel, M Maravic, JP Daures
  • Ann Rheum Dis
  • 2008
Highly Influential
1 Excerpt

An estimate of indirect cost savings in patients with early rheumatoid arthritis : sub - analysis of the premier health outcomes companion study [ abstract ]

  • RF VanVollenhoven, S Roy, S Ray
  • Ann Rheum Dis
  • 2008

Budget impact of rituximab ( Mabthera ) after failure of one or more TNF inhibitor therapies in the treatment of rheumatoid arthritis [ abstract ]

  • S Payet, C Francesconi, L RiouFranca
  • Curr Med Res Opin
  • 2008

Cost - effectiveness simulation model of abatacept versus rituximab in rheumatoid arthritis in France [ abstract ]

  • L Gossec, P Goupille, A Saraux
  • Abatacept for the treatment of rheumatoid…
  • 2008

Similar Papers

Loading similar papers…